Search Orphan Drug Designations and Approvals
-
Generic Name: | anti-HER2 bispecific antibody |
---|---|
Date Designated: | 05/18/2016 |
Orphan Designation: | Treatment of ovarian cancer |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 09/27/2021 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Zymeworks Inc. 1385 West 8th Street, Suite 540 Vancouver, BC V6H 3V9 Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-